TITLE

Premature Mortality from Cardiovascular Disease in the Americas – Will the Goal of a Decline of “25% by 2025” be Met?

AUTHOR(S)
Ordunez, Pedro; Prieto-Lara, Elisa; Pinheiro Gawryszewski, Vilma; Hennis, Anselm J. M.; Cooper, Richard S.
PUB. DATE
October 2015
SOURCE
PLoS ONE;29/10/2015, Vol. 10 Issue 10, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Cardiovascular diseases (CVD) are the underlying cause 1.6 million deaths per year in the Americas, accounting for 30% of total mortality and 38% of by non-communicable deaths diseases (NCDs). A 25% reduction in premature mortality due four main NCDs was targeted by the 2011 High-level Meeting of the General Assembly on the Prevention and Control of NCDs. While overall CVD mortality fell in the Americas during the past decade, trends in premature CVD mortality during the same period have not been described, particularly in the countries of Latin America and the Caribbean. Methods: This is a population-based trend-series study based on a total of 6,133,666 deaths to describe the trends and characteristics of premature mortality due to CVD and to estimates of the average annual percentage of change during the period 2000–2010 in the Americas. Findings: Premature mortality due to CVD in the Americas fell by 21% in the period 2000–2010 with a -2.5% average annual rate of change in the last 5 year—a statistically significant reduction of mortality—. Mortality from ischemic diseases, declined by 25% - 24% among men and 26% among women. Cerebrovascular diseases declined by 27% -26% among men and 28% among women. Guyana, Trinidad and Tobago, the Dominican Republic, Bahamas, and Brazil had CVD premature mortality rates over 200 per 100,000 population, while the average for the Region was 132.7. US and Canada will meet the 25% reduction target before 2025. Mexico, Costa Rica, Venezuela, Dominican Republic, Panama, Guyana, and El Salvador did not significantly reduce premature mortality among men and Guyana, the Dominican Republic, and Panama did not achieve the required annual reduction in women. Conclusions: Trends in premature mortality due to CVD observed in last decade in the Americas would indicate that if these trends continue, the Region as a whole and a majority of its countries will be able to reach the goal of a 25% relative reduction in premature mortality even before 2025.
ACCESSION #
110607223

 

Related Articles

  • Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease? Poredos, Pavel; Jezovnik, Mateja Kaja // International Journal of Molecular Sciences;Jul2015, Vol. 16 Issue 7, p14477 

    Atherosclerosis is considered a generalized disease. Similar or identical etiopathogenetic mechanisms and risk factors are involved in various atherosclerotic diseases, and the positive effects of preventive measures on atherogenesis in different parts of the arterial system were shown. However,...

  • Two-Year Vascular Event Rates in Patients with Symptomatic Cerebrovascular Disease: The REACH Registry. Venketasubramanian, Narayanaswamy; Röther, Joachim; Bhatt, Deepak L.; Pasquet, Blandine; Mas, Jean-Louis; Alberts, Mark J.; Hill, Michael D.; Aichner, Franz; Steg, P. Gabriel // Cerebrovascular Diseases;Sep2011, Vol. 32 Issue 3, p254 

    Background and Purpose: Few practice-based studies have reported vascular outcome events among patients with cerebrovascular disease (CeVD). We describe 2-year vascular outcomes among symptomatic CeVD patients from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Methods:...

  • Analyzing Recent Coronary Heart Disease Mortality Trends in Tunisia between 1997 and 2009 Saidi, Olfa; Ben Mansour, Nadia; O’Flaherty, Martin; Capewell, Simon; Critchley, Julia A.; Romdhane, Habiba Ben // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Background: In Tunisia, Cardiovascular Diseases are the leading causes of death (30%), 70% of those are coronary heart disease (CHD) deaths and population studies have demonstrated that major risk factor levels are increasing. Objective: To explain recent CHD trends in Tunisia between 1997 and...

  • Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease. Ding, Ding; Su, Dongfang; Li, Xinrui; Li, Zhongxia; Wang, Yujie; Qiu, Jian; Lin, Puqing; Zhang, Yuan; Guo, Pi; Xia, Min; Li, Dan; Yang, Yan; Hu, Gang; Ling, Wenhua // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: Monocyte chemoattractant protein-1 (MCP-1) is an important chemokine at multiple phases of atherosclerosis in animals, but human studies are few and inconsistent. The aim of this study is to investigate the association of serum MCP-1with all-cause and cardiovascular disease (CVD)...

  • Natriuretic Peptides and Cardiovascular Events. Konstam, Marvin A. // JAMA: Journal of the American Medical Association;1/10/2007, Vol. 297 Issue 2, p212 

    The article presents an editorial that discusses examining plasma levels of N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) to predict the occurrence of cardiovascular events in patients with cardiovascular disease. NT-proBNP is a product of brain-type...

  • BEAUTIFUL: no go for go slow with ivabradine?  // Heart;Jan2009, Vol. 95 Issue 2, p171 

    The article discusses the effectiveness of ivabradine, a heart-rate-lowering agent, in preventing cardiovascular death and mortality in patients with coronary heart disease and impaired systolic function. A BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with...

  • Hyperglycemia and Mortality Among Patients With Coronary Artery Disease. Ding Ding; Jian Qiu; Xinrui Li; Dan Li; Min Xia; Zhongxia Li; Dongfang Su; Yujie Wang; Yuan Zhang; Jinxia Zhang; Xiaofei Lv; Yunjun Xiao; Gang Hu; Wenhua Ling // Diabetes Care;Feb2014, Vol. 37 Issue 2, p546 

    OBJECTIVE Known diabetes is an independent predictor for mortality in coronary artery disease (CAD) patients; however, whether other glucose abnormalities are associated with death risk in CAD patients is unclear. The goal of this study was to examine the association between different glucose...

  • Methods and feasibility of collecting occupational data for a large population-based cohort study in the United States: the reasons for geographic and racial differences in stroke study. MacDonald, Leslie A.; Pulley, LeaVonne; Hein, Misty J.; Howard, Virginia J. // BMC Public Health;2014, Vol. 14 Issue 1, p1 

    Background Coronary heart disease and stroke are major contributors to preventable mortality. Evidence links work conditions to these diseases; however, occupational data are perceived to be difficult to collect for large population-based cohorts. We report methodological details and the...

  • Dietary patterns and cardiovascular mortality in the Melbourne Collaborative Cohort Study.  // American Journal of Clinical Nutrition;Jul2007, Vol. 86 Issue 1, p221 

    The article discusses a study which investigates the relation between dietary patterns and mortality from cardiovascular disease (CVD) and ischemic heart disease (IHD) in ethnic population in Australia. Topics include identifying four dietary factors from a food-frequency questionnaire (FFQ),...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics